logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kathrin I. Foerster

department of clinical pharmacology and pharmacoepidemiology
H指数:19
被引数:1,788

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteers

频繁使用的抗癫痫药物卡马西平、加巴喷丁和普瑞巴林对依度沙班及其他口服Xa因子抑制药在健康志愿者中的药代动力学影响

FRONTIERS IN PHARMACOLOGY
IF4.8
2025-04-110
OA
Lenard, Alexander; Hermann, Simon A.; Stoll, Felicitas; Burhenne, Juergen; Foerster, Kathrin I.; Czock, David; Mikus, Gerd; Meid, Andreas D.; Haefeli, Walter E.; Blank, Antje
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial
THROMBOSIS AND HAEMOSTASIS
IF4.3
2024-12-311
OAAI
Korompoki, Eleni; Heuschmann, Peter; Harvey, Kirsten H.; Fiessler, Cornelia; Malzahn, Uwe; Huegen, Klemens; Ullmann, Sabine; Todd, Gabriele Putz; Schuhmann, Carolin; Montaner, Joan; Sibon, Igor; Debette, Stephanie; Enzinger, Christian; Ropele, Stefan; Ruecker, Viktoria; Haas, Kirsten; Harvey, Emily; Wolfe, Charles; Wang, Yanzhong; Nielsen, Peter B.; Caso, Valeria; Lip, Gregory Y. H.; Lane, Deirdre A.; Halse, Omid; Ringleb, Peter; Haefeli, Walter E.; Foerster, Kathrin I.; Wurmbach, Viktoria S.; Veltkamp, Roland; PRESTIGE AF Investigators
The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models

一流的ERK抑制剂ulixertinib在促分裂原活化蛋白激酶 (MAPK) 驱动的儿科低度神经胶质瘤模型中显示出有希望的活性

NEURO-ONCOLOGY
IF13.4
2022-07-2716
OA
Sigaud, Romain; Roesch, Lisa; Gatzweiler, Charlotte; Benzel, Julia; von Soosten, Laura; Peterziel, Heike; Selt, Florian; Najafi, Sara; Ayhan, Simay; Gerloff, Xenia F.; Hofmann, Nina; Buedenbender, Isabel; Schmitt, Lukas; Foerster, Kathrin, I; Burhenne, Juergen; Haefeli, Walter E.; Korshunov, Andrey; Sahm, Felix; van Tilburg, Cornelis M.; Jones, David T. W.; Pfister, Stefan M.; Knoerzer, Deborah; Kreider, Brent L.; Sauter, Max; Pajtler, Kristian W.; Zuckermann, Marc; Oehme, Ina; Witt, Olaf; Milde, Till
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy

在不适合强化治疗的难治性/复发性AML患者中，tranylcypramine联合ATRA抑制LSD1的概念验证I/II期试点试验

LEUKEMIA
IF13.4
2020-06-1957
OAAI
Wass, Maxi; Goellner, Stefanie; Besenbeck, Birgit; Schlenk, Richard F.; Mundmann, Petra; Goethert, Joachim R.; Noppeney, Richard; Schliemann, Christoph; Mikesch, Jan-Henrik; Lenz, Georg; Dugas, Martin; Wermke, Martin; Roellig, Christoph; Bornhaeuser, Martin; Serve, Hubert; Platzbecker, Uwe; Foerster, Kathrin, I; Burhenne, Juergen; Haefeli, Walter E.; Mueller, Lutz P.; Binder, Mascha; Pabst, Caroline; Mueller-Tidow, Carsten
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia
CLINICAL EPIGENETICS
IF4.4
2019-12-1028
OAAI
van Tilburg, Cornelis M.; Milde, Till; Witt, Ruth; Ecker, Jonas; Hielscher, Thomas; Seitz, Angelika; Schenk, Jens-Peter; Buhl, Juliane L.; Riehl, Dennis; Fruhwald, Michael C.; Pekrun, Arnulf; Rossig, Claudia; Wieland, Regina; Flotho, Christian; Kordes, Uwe; Gruhn, Bernd; Simon, Thorsten; Linderkamp, Christin; Sahm, Felix; Taylor, Lenka; Freitag, Angelika; Burhenne, Jurgen; Foerster, Kathrin I.; Meid, Andreas D.; Pfister, Stefan M.; Karapanagiotou-Schenkel, Irini; Witt, Olaf

研究方向

暂未获取到该数据
J
Jürgen Burhenne
H 指数:57论文数:318被引数:9,751
W
Walter E. Haefeli
H 指数:74论文数:696被引数:2.2万
D
David Czock
H 指数:27论文数:183被引数:3,498
M
Mikus, Gerd
H 指数:0论文数:1被引数:49
A
Andreas D. Meid
H 指数:20论文数:88被引数:1,362
A
Andrea Huppertz
H 指数:11论文数:29被引数:640
A
Antje Blank
H 指数:26论文数:119被引数:2,932
F
Felicitas Stoll
H 指数:8论文数:24被引数:201
M
Max Sauter
H 指数:15论文数:68被引数:764
J
Johanna Weiß
H 指数:37论文数:194被引数:5,589